Phase II Trial

News Wire - 2018/10/15

Trial Will Build on the Positive, Pivotal Phase 3 PALISADE Trial of AR101.

Dave Bloom - 2018/09/27

Study scheduled to commence next week.

Dave Bloom - 2018/05/25

Study to provide evidence of longer lasting tolerance to peanut in a larger number of patients.

Dave Bloom - 2018/02/28

Announcements regarding two food allergy therapies that are in or advancing toward clinical trials were made yesterday.

Dave Bloom - 2017/12/12

Combining omalizumab with OIT is safe and effective for treating multiple food allergies simultaneously.

Dave Bloom - 2017/10/19

More exciting news as pharma companies work to extend the effectiveness of their therapies in combination.

Dave Bloom - 2017/03/08

Antibody targets trigger also implicated in other food allergies, atopic diseases, and asthma.

Dave Bloom - 2016/10/25

The study was designed to assess the long-term efficacy and safety of the treatment in subjects that had graduated from their earlier VIPES trial.

Dave Bloom - 2016/08/11

"The first-ever clinical study of preschoolers allergic to peanuts could lead to safe and effective treatment for millions of people."

Dave Bloom - 2015/06/30

The board overseeing the Phase I study of the milk allergy therapy found no safety concerns.

Tag: Phase II Trial